Clover Health CFO Joseph Wagner departs; Mark Herbers named interim CFO

CLOVER HEALTH INVESTMENTS, CORP. /DE

Joseph Wagner stepped down as CFO on August 13, 2021; will provide consulting services for 12 months at $10,000 per month.
Mark Herbers (Director at AlixPartners) appointed interim CFO; company pays $175,000 per month to APS for his services.
Herbers will serve as principal financial and accounting officer while permanent CFO search is conducted.
Separation agreement extends post-termination exercise period of Wagner's vested stock options by one year.
If consulting period is terminated early, company pays Wagner a lump sum equal to remaining monthly fees.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joseph Wagner

Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2021-08-13
Successor: Mark Herbers
Filed: August 16, 2021, 7:59 PM ET

On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, would be stepping down as an officer of the company on August 13, 2021 (the “Departure Date”).

Appointed (interim)

Mark Herbers

interim Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2021-08-13
Filed: August 16, 2021, 7:59 PM ET

On August 13, 2021, the Company’s Board of Directors appointed Mr. Herbers as interim Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Wagner departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: stepped down
Role: Chief Financial Officer

Exact text from the filing

On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, would be stepping down as an officer of the company on August 13, 2021 (the “Departure Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Herbers was appointed as interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

On August 13, 2021, the Company’s Board of Directors appointed Mr. Herbers as interim Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-21-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.